Here’s Why You Shouldn’t Compare Efficacy Numbers for the 3 COVID-19 Vaccines
Interview with Dr. Cameron Wolfe, an associate professor of medicine at Duke’s School of Medicine
Monday, March 08, 2021
Top Story
Duke in the News
Reiners Comments on Whether the SEC Will Approve a Cryptocurrency ETF
Quotes Lee Reiners, executive director of the Global Financial Markets Center at Duke Law
Landlords and Tenants Need Rapid Help in NC
Commentary by Joseph A. Smith Jr.
WHO Head Pushes for Waiver of Some Intellectual Property Rights for Coronavirus Vaccines, in Bid to Broaden Access
Features comments by Dr. Krishna Udayakumar, associate director for innovation at the Duke Global Health Institute
The Road to Reopening Won’t Be a Straight Line
Commentary co-authored by Dr. Mark McClellan, a former commissioner of the FDA and director of the Duke-Margolis Center for Health Policy
Homo Sapiens: The Water-Saving Ape
Covers Duke research; quotes Herman Pontzer, lead author and evolutionary anthropologist at Duke
North Carolina Sends 6-Year-Olds to Court. Why Some Say It’s Time for Change
Features comments by Peggy Nicholson, supervising attorney for Duke University’s Children’s Law Clinic
A Vaccine Against UTIs? New Mouse Study Brings Shot Closer
Covers Duke research; quotes senior study author Soman Abraham, a distinguished professor of pathology
Will Climate Change Threaten Raleigh’s Mighty Oaks? A Duke Professor Has Clues
Features the comments of biology professor Paul Manos, whose research includes a focus on the evolution of oaks
Experts: Opening Schools Could Mean Classrooms Become Incubators for Virus
Quotes Dr. Charlene Wong, an associate professor of pediatrics
When the Clock Stopped: The Three Days Last March That Changed Sports
Reflections by Jon Jackson, deputy athletic director at Duke